Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

<p>China Feihe, a leading infant formula milk player in China, is looking to raise USD300-400m of capital to fund its plant expansion in Canada and China. Feihe has been listed in the US and was privatized in 2013. In 2016, it attempted to raise USD600-800m but it didn't come to fruition. In this insight, we will cover the company's background, its privatization, the infant formula milk industry and compare the company to its peers. We aim to present to our readers information that is not well disclosed in the prospectus.</p>

China Feihe, a leading infant formula milk player in China, is looking to raise USD300-400m of capital to fund its plant expansion in Canada and China. Feihe has been listed in the US and was privatized in 2013. In 2016, it attempted to raise USD600-800m but it didn't come to fruition. In this insight, we will cover the company's background, its privatization, the infant formula milk industry and compare the company to its peers. We aim to present to our readers information that is not well disclosed in the prospectus.

China Feihe IPO Preview: Goat Bless Infant Formula Milk?

China

China Feihe Limited manufactures and sells dairy products. The Company provides infant milk formula products processing, production, marketing, and other services. China Feihe also sells infant milk formula products on some electronic commerce platforms.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Feihe (6186 HK)

China Feihe IPO Preview: Goat Bless Infant Formula Milk?

China Feihe, a leading infant formula milk player in China, is looking to raise USD300-400m of capital to fund its plant expansion in Canada and...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)